After the failure of the Royal Commission on Covid-19, we are all wondering ‘where to from here?’ We are not alone. The entire biotech industry is...
In his column Biosafety Now, Dr. Simon Wain-Hobson revisits controversial gain of function research conducted in 2014 funded by US NIH contract HHSN26620070001 which successfully...